Connecticut Innovations’ Regenerative Medicine Research Fund Awards $11 Million for Scientific Research

Share Article

Fund awards more than 20 scientists to advance biomedical and stem cell research.

News Image
These awards help scientists to start and complete some of the most advanced research being conducted in their respective fields.

BioInnovation Connecticut, managed by Connecticut Innovations (CI), the leading source of financing and ongoing support for Connecticut's innovative, growing companies, today announced that the Regenerative Medicine Research Fund (RMRF) has awarded $11 million to scientists who are conducting biomedical, embryonic or human adult stem cell research.

The fund, formerly the Connecticut Stem Cell Program, has allocated more than $90 million toward stem cell research since 2006. The funding has supported more than 190 cutting-edge research projects at Yale University, the University of Connecticut, Wesleyan University, The Jackson Laboratory and private companies.

“The result of this program and the research it funds pushes the field closer to translation and enables development of innovative research assays and clinical treatments for diseases and conditions that could potentially affect millions of people,” said Margaret Cartiera, vice president and fund manager of BioInnovation Connecticut at Connecticut Innovations. “These awards help scientists to start and complete some of the most advanced research being conducted in their respective fields.”

In 2014, the state broadened the fund’s scope to include funding stem cell research. The program’s funding now helps increase the speed in which research is conducted and commercialized.

“The broader mandate of the fund allows us to assist with research that is closer to the clinic and could have a significant impact on human health, revolutionizing the way we treat diseases and medical conditions,” said Cartiera. “The caliber of the advisory committee members and the streamlined peer review process helps us to identify the strongest research opportunities that align with our mission.”

For a complete list of 2015 RMRF awardees, visit: http://www.bioinnovationct.com/wp-content/uploads/2015/06/RMRF-Awards.xlsx.

For more information on qualifications, requirements, guidelines and applications for the BioInnovation Connecticut funds, visit http://www.bioinnovationct.com. For general questions related to the funds, please write: info(at)bioinnovationct(dot)com.

About Connecticut Innovations Inc.
Connecticut Innovations (CI) is the leading source of financing and ongoing support for Connecticut's innovative, growing companies. To maximize the growth potential of each business, CI tailors its solutions and often combines its funds with resources from other financial leaders to provide venture capital and strategic support for early-stage technology companies; flexible loans for established companies with new innovations; grants that support innovation and collaboration; and connections to its well-established network of partners and professionals. Through all these initiatives, CI has helped bring $4 billion in financing to Connecticut companies. The state’s most active early-stage investor, CI has created more than 26,000 jobs. For more information on CI, please visit http://www.ctinnovations.com.

About BioInnovation Connecticut
Managed by Connecticut Innovations, BioInnovation Connecticut helps innovators speed bioscience discoveries toward commercialization, which is made possible through two key funds: The Connecticut Bioscience Innovation Fund (CBIF) and the Regenerative Medicine Research Fund. For more information on BioInnovation Connecticut, please visit http://www.bioinnovationct.com.

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Lauren Carmody
Visit website